Metastatic bone disease (2021 – CME) – online course
Authors: F. Deschamps and B. Gonçalves
Reviewers: M. Burgmans, R.L. Cazzato, L. Crocetti, D. Filippiadis, C. Nice and K. Pyra
This course corresponds to chapter 126.96.36.199 Fundamental IO in the European Curriculum and Syllabus for IR.
Bone is the third most common site for metastasis. Metastatic bone disease is predominantly found in the central bones of the body, most commonly in the spine but also in the pelvis (hip bone), proximal femur, humerus, ribs and in the skull. Metastatic bone sites are rarely able to be cured because of a major component – bone marrow – that acts as an easy deposit and a way for the tumour cells to spread to other tissues. Thus, finding and treating bone metastases early can help prevent other problems later in the disease as well as the patient performance status (PST).
- Know which techniques must be used for the treatment of bone metastases according to the clinical presentation
- Understand the different mechanisms of pain in patients suffering from bone metastases
- Learn how to choose the right materials to perform correct, easy and safe bone access
- Know the indication and the limits of cementoplasty for bone metastases
- Understand the rationale for “augmented” cementoplasty compared to cementoplasty alone and know when it should be used
- Know the differences between ablative techniques and their limitations
- Learn how to achieve good outcomes according to different ablation techniques
This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the European Curriculum and Syllabus for IR and corresponds to chapter 188.8.131.52 Fundamental IO.
The format of the course is interactive and easy to use, including texts, graphics, videos and a quiz to support your learning. The course duration is around one hour and is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to award 1 European CME credit (ECMEC). The CME accreditation for this course will expire on February 18, 2023. A non-CME accredited version of the course will remain available until the new CME accredited course is published.
Upon purchase, access to complete and revisit the course is granted for an enrolment period of 90 days.
The CME certificate will be available in the myCIRSE area past the enrolment period if the course is completed before February 18, 2023.
Release date: February 2021